<DOC>
	<DOCNO>NCT00596804</DOCNO>
	<brief_summary>This study do assess safety tolerance different dos humanize hA20 patient NHL .</brief_summary>
	<brief_title>Safety Study Different Doses hA20 ( Veltuzumab ) CD20+ Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Male female , &gt; 18 year old Histological diagnosis CD20+ Bcell NHL ( grade ) WHO lymphoma criterion Failed least one prior standard chemotherapy regimen NHL Failed rituximab treatment relapse NHL Measurable NHL disease CT , least one lesion &gt; 1.5 cm one dimension Adequate performance status ( &gt; 70 Karnofsky scale , 01 ECOG ) estimate life expectancy least 6 month Adequate hematologic status , without ongoing transfusional support ( hemoglobin ≥ 10 g/dL , ANC ≥ 1.5 × 109/L , platelet ≥ 100 × 109/L ) Adequate renal hepatic function , define : creatinine ≤ 1.5 x Institution Upper Limit Normal ( IULN ) , bilirubin ≤ 1.5 x IULN , AST ALT ≤ 2.5 x IULN Otherwise , &lt; Grade 1 toxicity study entry NCI CTC version 2.0 , include recovery acute toxicity incur result previous surgery , radiotherapy chemotherapy , whether investigational conventional . At least 6 month beyond previous rituximab treatment , 12 week beyond autologous stem cell transplant , 4 week beyond chemotherapy , experimental treatment , radiation therapy index lesion ( ) . Ability provide sign , informed consent Pregnant lactate woman . Women childbearing potential require negative pregnancy test Women childbearing potential fertile men practice unwilling practice birth control enrol study least 12 week last weekly hA20 infusion . Rituximab resistant , define progress within 6 month rituximab treatment . Excessive toxicity rituximab ( NCI CTC Grade 3 4 ) know HACA positive Prior radioimmunotherapy , include Zevalin Bexxar , Prior therapy human humanize monoclonal antibody , unless HAHA test negative Primary CNS lymphoma , HIV lymphoma transform lymphoma , presence symptomatic CNS metastases carcinomatous meningitis . Bulky disease CT , define single mass &gt; 10 cm great diameter Pleural effusion positive cytology lymphoma Known HIV positive , hepatitis B C positive Known autoimmune disease presence autoimmune phenomenon . Evidence infection require antibiotic within 5 day . Corticosteroid use within 2 week Prior malignancy le 5year diseasefree interval , exclude nonmelanoma skin cancer carcinoma situ cervix . Other concurrent medical psychiatric condition , Investigator 's opinion , may likely confound study interpretation prevent completion studyprocedures followup examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>NHL</keyword>
	<keyword>Non-Hodgkin 's lymphoma</keyword>
	<keyword>follicular lymphoma</keyword>
	<keyword>B-cell lymphoma</keyword>
	<keyword>diffuse large cell lymphoma</keyword>
	<keyword>small lymphoctytic lymphoma</keyword>
	<keyword>Mantle cell lymphoma</keyword>
	<keyword>MALT</keyword>
	<keyword>marginal zone lymphoma</keyword>
	<keyword>High-Grade</keyword>
	<keyword>Intermediate-Grade</keyword>
	<keyword>Low-Grade</keyword>
	<keyword>Mixed</keyword>
</DOC>